SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001558370-24-006147
Filing Date
2024-04-29
Accepted
2024-04-29 17:05:47
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-29

Document Format Files

Seq Description Document Type Size
1 ARS ymab-20231231xars.pdf ARS 1597013
  Complete submission text file 0001558370-24-006147.txt   2201062
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38650 | Film No.: 24892425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)